|
Test model | Dose (mg/kg) | Route | Mechanism of action | Reference |
|
Model of nociception based on the writhing response generated by acetic acid, formalin-induced paw licking test, and hot plate test in mice | MeOH, n-hexane, and EtOAc extracts of A. corniculatum (stem) (1–100 mg/kg) | Intraperitoneal | The MeOH extract may potentially elicit a central antinociceptive effect through the activation of κ-opioid receptors and the inhibition of prostaglandin biosynthesis | [41] |
The n-hexane extract functions by activating the peripheral opioid receptors as an opioid agonist, thereby counteracting the symptoms of withdrawal abstinence syndrome through the GABAB receptor |
The neurogenic analgesic effect of the EtOAc extract was not attributed to the opioidergic system, but it may exert its impact by inhibiting the synthesis of proinflammatory PGs |
|
CCl4-induced hepatotoxicity in rats | MeOH, n-hexane, and EtOAc extracts of A. corniculatum (stem) (250–1000 mg/kg) | Oral | The n-hexane and ethyl acetate extracts have the potential to sequester harmful substances such as trichloromethyl and its peroxy radicals, thereby reducing cellular damage. Additionally, these extracts may exhibit a hepatoprotective effect by inhibiting drug-metabolizing enzymes, specifically cytochrome P-450. | [27] |
|
Glucose oxidase-induced paw edema in mice | MeOH, n-hexane, and EtOAc extracts of A. corniculatum (stem) (10, 50, and 100 mg/kg) | Oral | Suppression of proinflammatory mediator synthesis under conditions of oxidative stress | [27] |
|
Alloxan-induced diabetic male albino rats | ACEt extract of A. corniculatum leaves (25, 50, and 100 mg/kg body weight) for 60 days | Oral | The activity of hexokinase has been observed to be elevated, while the activities of glucose 6-phosphatase and fructose-1,6-bisphosphatase have been found to be reduced | [42] |
|
Carrageenan-induced rat paw edema and glycogen-induced peritonitis models | MeOH, n-hexane, and EtOAc extracts (1–100 mg/kg) derived from A. corniculatum (stems) | Intraperitoneal | MeOH extract inhibits the COX-1 metabolite, 12-HHT, while increasing the 12-LOX metabolite, 12-HETE | [43] |
Hexane extract reduced 12-HETE synthesis while increasing 12-HHT, and it inhibited the development of 5-LOX metabolites such as leukotriene B4 and 5-HETE |
The EtOH extract demonstrated inhibitory effects on both COX and 5-LOX enzymes, leading to a notable reduction in the production of 12-HHT and LTB4 |
|
Antiplasmodial activity in adult male albino rats | 15, 30, 60, 120, and 200 mg/kg of polyherbal extracts of A. corniculatum | Oral | N/A | [44] |
|
Antitumor activity in HT-29 colon cancer cell injected male nude mice | n-Butanol extract of A. corniculatum leaves (25 mg/kg) once daily for 18 consecutive days | Oral | The activation of forkhead box proteins by the extract regulates cell cycle checkpoint pathways that are associated with caspase-dependent mitochondrial apoptotic cascades and Bcl-2 family proteins. This leads to cellular apoptosis and arrest of the cell cycle. | [10] |
|
Chronic granulomatous inflammation and arthritis test in albino rats | MeOH extract (10, 25, 50, and 100 mg/kg) and acetyl acetate extract (10, 25, 50, 100, and 200 mg/kg) derived from A. corniculatum leaves | Oral | Both extracts effectively decrease chronic inflammation, preventing mononuclear cell infiltration, fibroblast proliferation, collagen fiber production, and granuloma progress | [45] |
|
Acetic acid-induced writhing test and tail immersion test in Swiss albino mice | MeOH extract of A. corniculatum (leaves) (125, 250, and 500 mg/kg) | Oral | Inhibit the enzyme prostaglandin synthetase | [46] |
|
Carrageenan-induced lung injury in Swiss mouse using pleurisy model | MeOH and EtOAc extract (10, 50, and 100 mg/kg) | Oral | The decline of nitrate/nitrite concentrations and MPO enzyme levels and reduction of neutrophils and mononuclear infiltration | [47] |
|
MWM test for scopolamine-induced amnesia in aged Swiss albino mice | MeOH extract of Aegiceras corniculatum (AC) leaves at doses of 50 and 100 mg/kg for 7 days | Oral | The activity of acetylcholinesterase (AChE), the levels of thiobarbituric acid reactive substances (TBARS), and reactive oxygen species (ROS) were notably reduced | [48] |
|